Overview
FDA & Trial Timeline
2 eventstreatment of Rett syndrome in adults and pediatric patients 2 years of age and older
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
1 availableMAVYRET
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor…
MAVYRET is indicated for the treatment of adult and pediatric patients 3 years and older with HCV genotype 1 infection, who previously have been treated with a regimen containing an HCV NS5A inhibitor or an NS3/4A protease inhibitor (PI), but not both
Clinical Trials
View all trials with filters →No actively recruiting trials found for Post 5-alpha-reductase inhibitors treatment syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Post 5-alpha-reductase inhibitors treatment syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Financial Resources
1 resourcesDaybue
Acadia Pharmaceuticals Inc.
Travel Grants
No travel grants are currently matched to Post 5-alpha-reductase inhibitors treatment syndrome.
Community
No community posts yet. Be the first to share your experience with Post 5-alpha-reductase inhibitors treatment syndrome.
Start the conversation →Latest news about Post 5-alpha-reductase inhibitors treatment syndrome
No recent news articles for Post 5-alpha-reductase inhibitors treatment syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Post 5-alpha-reductase inhibitors treatment syndrome
What treatment and support options exist for Post 5-alpha-reductase inhibitors treatment syndrome?
1 patient support program are currently tracked on UniteRare for Post 5-alpha-reductase inhibitors treatment syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.